The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Werner Scheithauer

Department of Internal Medicine I

Division of Oncology

Vienna University Medical School

Vienna

[email]@akh-wien.ac.at

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Internal Medicine I, Division of Oncology, Vienna University Medical School, Vienna. 2001 - 2003

References

  1. Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Schüll, B., Schmid, K., Kovats, E., Schneeweiss, B., Lang, F., Lenauer, A., Depisch, D. J. Clin. Oncol. (2003) [Pubmed]
  2. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Scheithauer, W., McKendrick, J., Begbie, S., Borner, M., Burns, W.I., Burris, H.A., Cassidy, J., Jodrell, D., Koralewski, P., Levine, E.L., Marschner, N., Maroun, J., Garcia-Alfonso, P., Tujakowski, J., Van Hazel, G., Wong, A., Zaluski, J., Twelves, C. Ann. Oncol. (2003) [Pubmed]
  3. Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Ulrich-Pur, H., Fiebiger, W., Gedlicka, C., Schüll, B., Brugger, S., Schneeweiss, B., Lang, F., Lenauer, A., Depisch, D. J. Clin. Oncol. (2002) [Pubmed]
  4. Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Schüll, B., Schmid, K., Längle, F., Huber, H. Ann. Oncol. (2002) [Pubmed]
  5. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor. Kornek, G.V., Ulrich-Pur, H., Penz, M., Haider, K., Kwasny, W., Depisch, D., Kovats, E., Lang, F., Schneeweiss, B., Scheithauer, W. J. Clin. Oncol. (2001) [Pubmed]
  6. Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial. Scheithauer, W., Kornek, G.V., Ulrich-Pur, H., Penz, M., Raderer, M., Salek, T., Haider, K., Kwasny, W., Depisch, D. Cancer (2001) [Pubmed]
  7. Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy. Scheithauer, W., Kornek, G.V., Schuell, B., Ulrich-Pur, H., Penz, M., Raderer, M., Lang, F., Schneeweiss, B., Lenauer, A., Depisch, D. Ann. Oncol. (2001) [Pubmed]
 
WikiGenes - Universities